Tumor-Induced Osteoclast miRNA Changes as Regulators and Biomarkers of Osteolytic Bone Metastasis
Open accessAbstract
Understanding the mechanism by which tumor cells influence osteoclast differentiation is crucial for improving treatment of osteolytic metastasis. Here, we report broad microRNA (miRNA) expression changes in differentiating osteoclasts after exposure to tumor-conditioned media, in part through activation of NFκB signaling by soluble intracellular adhesion molecule (sICAM1) secreted from bone-metastatic cancer cells. Ectopic expression of multiple miRNAs downregulated during osteoclastogenesis suppresses osteoclast differentiation by targeting important osteoclast genes. Intravenous delivery of these miRNAs in vivo inhibits osteoclast activity and reduces osteolytic bone metastasis. Importantly, serum levels of sICAM1 and two osteoclast miRNAs, miR-16 and miR-378, which are elevated in osteoclast differentiation, correlate with bone metastasis burden. These findings establish miRNAs as potential therapeutic targets and clinical biomarkers of bone metastasis.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Exosome transport solves the problem of easy degradation of miRNAs in vivo, implying a new tumor therapy.
“Furthermore, exosome transport solves the problem of easy degradation of miRNAs in vivo, implying a new tumor therapy [50].”
From The Therapeutic Potential and Clinical Significance of Exosomes as Carriers of Drug Delivery System (2022) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068 · see citing works
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670 · see citing works
Combinatorial microRNA target predictions
Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603 · see citing works
MicroRNA Targeting Specificity in Mammals: Determinants beyond Seed Pairing
Grimson, A., Farh, K. K.-H., Johnston, W. K., Garrett-Engele, P., Lim, L. P., & Bartel, D. P. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.017 · Cited by 3,766 · see citing works
Causes and consequences of microRNA dysregulation in cancer
Croce, C. M. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2634 · Cited by 3,003 · see citing works
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Käkönen, S.-M., Cordon‐Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,562 · see citing works
Leukocyte-endothelial adhesion molecules
Carlos, T., & Harlan, J. (1994) · Blood · doi:10.1182/blood.v84.7.2068.bloodjournal8472068 · Cited by 2,500 · see citing works
Leukocyte-endothelial adhesion molecules
Carlos, T., & Harlan, J. (1994) · Blood · doi:10.1182/blood.v84.7.2068.2068 · Cited by 1,957 · see citing works
Genetic regulation of osteoclast development and function
Teitelbaum, S. L., & Ross, F. (2003) · Nature reviews genetics · doi:10.1038/nrg1122 · Cited by 1,733 · see citing works
The Diverse Functions of MicroRNAs in Animal Development and Disease
Kloosterman, W. P., & Plasterk, R. H. A. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.09.009 · Cited by 1,714 · see citing works
Holmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kromer, M., Kuznetsov, S. A., Mankani, M., Gehron Robey, P., Poole, A. R., Pidoux, I., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80064-1 · Cited by 1,298 · see citing works
Cancer to bone: a fatal attraction
Weilbaecher, K. N., Guise, T. A., & McCauley, L. K. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3055 · Cited by 1,283 · see citing works
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signalingPreprint
Lomaga, M. A., Yeh, W., Sarosi, I., Duncan, G. S., Furlonger, C. L., Ho, A. P., Morony, S., Capparelli, C., Van, G. Y., Kaufman, S., et al. (1999) · Genes & Development · doi:10.1101/gad.13.8.1015 · Cited by 1,253 · see citing works
Hodgkinson, C. A., Moore, K. J., Nakayama, A., Steingrı́msson, E., Copeland, N. G., Jenkins, N. A., & Arnheiter, H. (1993) · Cell · doi:10.1016/0092-8674(93)90429-t · Cited by 1,092 · see citing works
Sethi, N. S., Dai, X., Winter, C. G., & Kang, Y. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.022 · Cited by 573 · see citing works
Lü, X., Mu, E. W., Wei, Y., Riethdorf, S., Yang, Q., Yuan, M., Yan, J., Hua, Y., Tiede, B., Lu, X., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.11.002 · Cited by 494 · see citing works
A novel orthotopic model of breast cancer metastasis to bone
Lelekakis, M., Moseley, J. M., Martin, T. J., Hards, D. K., Williams, E. D., Ho, P. W. M., Lowen, D., Javni, J. A., Miller, F. R., Slavin, J., et al. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006689719505 · Cited by 428 · see citing works
A microRNA expression signature of osteoclastogenesis
Sugatani, T., Vacher, J., & Hruska, K. A. (2011) · Blood · doi:10.1182/blood-2010-10-311415 · Cited by 275 · see citing works
Impaired Micro-RNA Pathways Diminish Osteoclast Differentiation and Function
Sugatani, T., & Hruska, K. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805777200 · Cited by 233 · see citing works
Korpal, M., Yan, J., Lü, X., Xu, S., Lerit, D. A., & Kang, Y. (2009) · Nature Medicine · doi:10.1038/nm.1943 · Cited by 217 · see citing works
MicroRNA‐223 is a key factor in osteoclast differentiation
Sugatani, T., & Hruska, K. A. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21335 · Cited by 194 · see citing works
MITF and PU.1 Recruit p38 MAPK and NFATc1 to Target Genes during Osteoclast Differentiation
Sharma, S. M., Bronisz, A., Hu, R., Patel, K., Mansky, K. C., Sif, S., & Ostrowski, M. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609723200 · Cited by 174 · see citing works
Linkage of M-CSF Signaling to Mitf, TFE3, and the Osteoclast Defect in Mitfmi/mi Mice
Weilbaecher, K. N., Motyckova, G., Huber, W. E., Takemoto, C. M., Hemesath, T. J., Xu, Y., Hershey, C. L., Dowland, N., Wells, A. G., & Fisher, D. E. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00360-4 · Cited by 168 · see citing works
Osteoclast‐specific Dicer gene deficiency suppresses osteoclastic bone resorption
Mizoguchi, F., Izu, Y., Hayata, T., Hemmi, H., Nakashima, K., Nakamura, T., Kato, S., Miyasaka, N., Ezura, Y., & Noda, M. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22228 · Cited by 167 · see citing works
Flamini, E., Mercatali, L., Nanni, O., Calistri, D., Nunziatini, R., Zoli, W., Rosetti, P., Gardini, N., Lattuneddu, A., Verdecchia, G. M., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1931 · Cited by 132 · see citing works
Hershey, C. L., & Fisher, D. E. (2003) · Bone · doi:10.1016/j.bone.2003.08.014 · Cited by 126 · see citing works
MT1-MMP Is Required for Myeloid Cell Fusion via Regulation of Rac1 Signaling
Gonzalo, P., Guadamillas, M. C., Hernández-Riquer, M. V., Pollán, Á., Grande-García, A., Bartolomé, R. A., Vasanji, A., Ambrogio, C., Chiarle, R., Teixidó, J., et al. (2010) · Developmental Cell · doi:10.1016/j.devcel.2009.11.012 · Cited by 125 · see citing works
Interferon‐β‐induced miR‐155 inhibits osteoclast differentiation by targeting SOCS1 and MITF
Zhang, J., Zhao, H., Chen, J., Xia, B., Jin, Y., Wei, W., Shen, J., & Huang, Y. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.06.047 · Cited by 120 · see citing works
Ell, B. J., & Kang, Y. (2012) · Cell · doi:10.1016/j.cell.2012.10.005 · Cited by 115 · see citing works
RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II
Hemingway, F., Taylor, R., Knowles, H. J., & Athanasou, N. A. (2010) · Bone · doi:10.1016/j.bone.2010.12.023 · Cited by 112 · see citing works
miRNA-based mechanism for the commitment of multipotent progenitors to a single cellular fate
Mann, M., Barad, O., Agami, R., Geiger, B., & Hornstein, E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915022107 · Cited by 108 · see citing works
Therapeutic targets for bone metastases in breast cancer
Clézardin, P. (2011) · Breast Cancer Research · doi:10.1186/bcr2835 · Cited by 108 · see citing works
Global secretome analysis identifies novel mediators of bone metastasis
Blanco, M. A., LeRoy, G., Khan, Z., Alečković, M., Zee, B. M., Garcia, B. A., & Kang, Y. (2012) · Cell Research · doi:10.1038/cr.2012.89 · Cited by 96 · see citing works
The Roles of MicroRNAs in the Cancer Invasion-Metastasis Cascade
Le, X., Merchant, O., Bast, R. C., & Calin, G. A. (2010) · Cancer Microenvironment · doi:10.1007/s12307-010-0037-4 · Cited by 93 · see citing works
Calcitonin Receptor Plays a Physiological Role to Protect Against Hypercalcemia in Mice
Davey, R. A., Turner, A. G., McManus, J. F., Chiu, W. M., Tjahyono, F., Moore, A. J., Atkins, G. J., Anderson, P. H., Ma, C., Glatt, V., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080310 · Cited by 87 · see citing works
Integrins and Cytokines Activate Nuclear Transcription Factor-κB in Human Neutrophils
Kettritz, R., Choi, M., Rolle, S., Wellner, M., & Luft, F. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309778200 · Cited by 77 · see citing works
Involvement of adhesion molecules LFA-1 and ICAM-1 in osteoclast development
Kurachi, T., Morita, I., & Murota, S. (1993) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(93)90202-z · Cited by 70 · see citing works
Nakano, K., Okada, Y., Saito, K., & Tanaka, Y. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20367 · Cited by 69 · see citing works
Chaffer, C. L., Dopheide, B., McCulloch, D. R., Lee, A. B., Moseley, J. M., Thompson, E. W., & Williams, E. D. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-5141-3 · Cited by 55 · see citing works
Harada, H., Kukita, T., Kukita, A., Iwamoto, Y., & Iijima, T. (1998) · Endocrinology · doi:10.1210/endo.139.9.6171 · Cited by 47 · see citing works
Aggregation of β2 integrins activates human neutrophils through the IκB/NF-κB pathway
Kim, C. H., Lee, K., Lee, C., Kim, Y. W., Han, S. K., Shim, Y.-S., & Yoo, C. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0103038 · Cited by 33 · see citing works
Quattrocchi, C. C., Dell’Aia, P., Errante, Y., Occhicone, F., Longo, D., Virzì, V., Tonini, G., Napoli, N., Santini, D., & Zobel, B. B. (2012) · Journal of bone oncology · doi:10.1016/j.jbo.2012.02.001 · Cited by 5 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Metastatic colonization by circulating tumour cells
Massagué, J., & Obenauf, A. C. (2016) · Nature · doi:10.1038/nature17038 · Cited by 2,062 · see citing works
Characteristics and Significance of the Pre-metastatic Niche
Liu, Y., & Cao, X. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.09.011 · Cited by 1,287 · see citing works
Clinical relevance of circulating cell-free microRNAs in cancer
Schwarzenbach, H., Nishida, N., Călin, G. A., & Pantel, K. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.5 · Cited by 1,091 · see citing works
Zeng, Z., Li, Y., Pan, Y., Lan, X.-L., Song, F., Sun, J., Zhou, K., Liu, X., Ren, X., Wang, F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07810-w · Cited by 995 · see citing works
Tumor metastasis: moving new biological insights into the clinic
Wan, L., Pantel, K., & Kang, Y. (2013) · Nature Medicine · doi:10.1038/nm.3391 · Cited by 746 · see citing works
Metastatic Stem Cells: Sources, Niches, and Vital Pathways
Óskarsson, T., Batlle, E., & Massagué, J. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.02.002 · Cited by 702 · see citing works
Coleman, R. E., Croucher, P. I., Padhani, A. R., Clézardin, P., Chow, E., Fallon, M., Guise, T. A., Colangeli, S., Capanna, R., & Costa, L. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00216-3 · Cited by 610 · see citing works
Surviving at a Distance: Organ-Specific Metastasis
Obenauf, A. C., & Massagué, J. (2015) · Trends in cancer · doi:10.1016/j.trecan.2015.07.009 · Cited by 569 · see citing works
Biology, detection, and clinical implications of circulating tumor cells
Joosse, S. A., Gorges, T. M., & Pantel, K. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201303698 · Cited by 531 · see citing works
Understanding the Bone in Cancer Metastasis
Fornetti, J., Welm, A. L., & Stewart, S. A. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3618 · Cited by 528 · see citing works
Data Normalization Strategies for MicroRNA Quantification
Schwarzenbach, H., da Silva, A. M., Calin, G., & Pantel, K. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.239459 · Cited by 426 · see citing works
Bone metastasis: mechanisms, therapies, and biomarkers
Clézardin, P., Coleman, R., Puppo, M., Ottewell, P. D., Bonnelye, E., Paycha, F., Confavreux, C. B., & Holen, I. (2020) · Physiological Reviews · doi:10.1152/physrev.00012.2019 · Cited by 427 · see citing works
Cancer stem cells: The root of tumor recurrence and metastases
Peitzsch, C., Tyutyunnykova, A., Pantel, K., & Dubrovska, A. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.02.011 · Cited by 371 · see citing works
Osteoclast-derived microRNA-containing exosomes selectively inhibit osteoblast activity
Sun, W., Zhao, C., Li, Y., Wang, L., Nie, G., Peng, J., Wang, A., Zhang, P., Tian, W., Li, Q., et al. (2016) · Cell Discovery · doi:10.1038/celldisc.2016.15 · Cited by 308 · see citing works
Krzeszinski, J. Y., Wei, W., Huynh, H., Jin, Z., Wang, X., Chang, T.-C., Xie, X., He, L., Mangala, L. S., Lopez‐Berestein, G., et al. (2014) · Nature · doi:10.1038/nature13375 · Cited by 303 · see citing works
RetractedEsposito, M., Mondal, N., Greco, T. M., Wei, Y., Spadazzi, C., Lin, S.-C., Zheng, H., Cheung, C., Magnani, J. L., Lin, S.-H., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0309-2 · Cited by 250 · see citing works
MicroRNAs and metastasis: small RNAs play big roles
Kim, J., Yao, F., Xiao, Z., Sun, Y., & Ma, L. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9712-y · Cited by 236 · see citing works
Deng, R., Zhang, H., Huang, J.-H., Cai, R., Wang, Y., Chen, Y., Hu, B., Ye, Z.-P., Li, Z., Mai, J., et al. (2020) · Autophagy · doi:10.1080/15548627.2020.1850609 · Cited by 234 · see citing works
Exosomes as drug carriers for cancer therapy and challenges regarding exosome uptake
Zhao, X., Wu, D. L., Ma, X., Wang, J., Hou, W., & Zhang, W. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110237 · Cited by 220 · see citing works
MicroRNA regulons in tumor microenvironment
Suzuki, H. I., Katsura, A., Matsuyama, H., & Miyazono, K. (2014) · Oncogene · doi:10.1038/onc.2014.254 · Cited by 208 · see citing works
Novel approaches to target the microenvironment of bone metastasis
Hofbauer, L. C., Bözec, A., Rauner, M., Jakob, F. J., Perner, S., & Pantel, K. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00499-9 · Cited by 213 · see citing works
Ji, H., Chen, M.-S., Greening, D., He, W., Rai, A., Zhang, W.-W., & Simpson, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110314 · Cited by 199 · see citing works
miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13
Zhang, P., Wang, L., Rodriguez‐Aguayo, C., Yuan, Y., Debeb, B. G., Chen, D., Sun, Y., You, M. J., Liu, Y., Dean, D. C., et al. (2014) · Nature Communications · doi:10.1038/ncomms6671 · Cited by 188 · see citing works
Croset, M., Pantano, F., Kan, C. W. S., Bonnelye, E., Descôtes, F., Alix‐Panabières, C., Lecellier, C., Bachelier, R., Allioli, N., Hong, S. S., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3058 · Cited by 188 · see citing works
Taipaleenmäki, H., Browne, G., Akech, J., Zustin, J., van Wijnen, A. J., Stein, J. L., Hesse, E., Stein, G. S., & Lian, J. B. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1026 · Cited by 180 · see citing works
Exosomal micro RNA s as tumor markers in epithelial ovarian cancer
Pan, C., Stevic, I., Müller, V., Ni, Q., Oliveira‐Ferrer, L., Pantel, K., & Schwarzenbach, H. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12371 · Cited by 176 · see citing works
Bone metastasis and the metastatic niche
Ren, G., Esposito, M., & Kang, Y. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1329-4 · Cited by 161 · see citing works
Zheng, H., Bae, Y., Kasimir‐Bauer, S., Tang, R. B., Chen, J., Ren, G., Yuan, M., Esposito, M., Li, W., Wei, Y., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.11.002 · Cited by 161 · see citing works
Clinical and molecular complexity of breast cancer metastases
Kimbung, S., Loman, N., & Hedenfalk, I. A. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.08.009 · Cited by 149 · see citing works
The Role of miR-378a in Metabolism, Angiogenesis, and Muscle Biology
Krist, B., Florczyk, U., Pietraszek‐Gremplewicz, K., Józkowicz, A., & Dulak, J. (2015) · International Journal of Endocrinology · doi:10.1155/2015/281756 · Cited by 146 · see citing works
Hypoxia‐Inducible Exosomes Facilitate Liver‐Tropic Premetastatic Niche in Colorectal Cancer
Sun, H., Meng, Q., Shi, C., Yang, H., Li, X., Wu, S., Familiari, G., Relucenti, M., Aschner, M., Wang, X., et al. (2021) · Hepatology · doi:10.1002/hep.32009 · Cited by 143 · see citing works
Amin, N., Afkhami, A., Hosseinzadeh, L., & Madrakian, T. (2018) · Analytica Chimica Acta · doi:10.1016/j.aca.2018.05.014 · Cited by 136 · see citing works
Colden, M., Dar, A. A., Saini, S., Dahiya, P. V., Shahryari, V., Yamamura, S., Tanaka, Y., Stein, G. S., Dahiya, R., & Majid, S. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.15 · Cited by 134 · see citing works
The role of MicroRNAs in Osteoclasts and Osteoporosis
Tang, P., Xiong, Q., Ge, W., & Zhang, L. (2014) · RNA Biology · doi:10.1080/15476286.2014.996462 · Cited by 133 · see citing works
Metastasis of circulating tumor cells: Favorable soil or suitable biomechanics, or both?
Azevedo, A. S., Follain, G., Patthabhiraman, S., Harlepp, S., & Goetz, J. G. (2015) · Cell Adhesion & Migration · doi:10.1080/19336918.2015.1059563 · Cited by 126 · see citing works
Targeting bone metastases in prostate cancer: improving clinical outcome
Body, J., Casimiro, S., & Costa, L. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.90 · Cited by 123 · see citing works
Cancer Cell Colonisation in the Bone Microenvironment
Kan, C. W. S., Vargas, G., Pape, F. L., & Clézardin, P. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101674 · Cited by 116 · see citing works
Ma, Z., Wei, K., Yang, F., Guo, Z., Pan, C., He, Y., Wang, J., Li, Z., Chen, L., Chen, Y., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04037-4 · Cited by 112 · see citing works
Overexpression and knockout of miR-126 both promote leukemogenesis
Li, Z., Chen, P., Su, R. J., Li, Y., Hu, C., Wang, Y., Arnovitz, S., He, M., Gurbuxani, S. K., Zuo, Z., et al. (2015) · Blood · doi:10.1182/blood-2015-04-639062 · Cited by 111 · see citing works
The Therapeutic Potential and Clinical Significance of Exosomes as Carriers of Drug Delivery System
Li, T., Li, X., Han, G., Liang, M., Yang, Z., Zhang, C., Huang, S., Tai, S., & Yu, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics15010021 · Cited by 110 · see citing works
Considering Exosomal miR-21 as a Biomarker for Cancer
Shi, J. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5040042 · Cited by 109 · see citing works
Wu, X., Zhang, W., Font-Burgada, J., Palmer, T. D., Hamil, A. S., Biswas, S. K., Poidinger, M., Borcherding, N. C., Xie, Q. M., Ellies, L. G., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414358111 · Cited by 105 · see citing works
Inder, K. L., Ruelcke, J. E., Petelin, L., Moon, H., Choi, E. A., Rae, J., Blumenthal, A., Hutmacher, D. W., Saunders, N. A., Stow, J. L., et al. (2014) · Journal of Extracellular Vesicles · doi:10.3402/jev.v3.23784 · Cited by 101 · see citing works
Non-coding RNAs: Epigenetic regulators of bone development and homeostasis
Hassan, M. Q., Tye, C. E., Stein, G. S., & Lian, J. B. (2015) · Bone · doi:10.1016/j.bone.2015.05.026 · Cited by 102 · see citing works
Stückrath, I., Rack, B. K., Janni, W., Jäger, B., Pantel, K., & Schwarzenbach, H. (2015) · Oncotarget · doi:10.18632/oncotarget.3874 · Cited by 101 · see citing works
Osteoclast Signal Transduction During Bone Metastasis Formation
Győri, D., & Mócsai, A. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00507 · Cited by 104 · see citing works
Kim, M. Y. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9620-6_9 · Cited by 101 · see citing works
Mercatali, L., Manna, F. L., Groenewoud, A., Casadei, R., Recine, F., Miserocchi, G., Pieri, F., Liverani, C., Bongiovanni, A., Spadazzi, C., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081375 · Cited by 101 · see citing works
Molecular Mechanisms of Bone Metastasis and Associated Muscle Weakness
Waning, D. L., & Guise, T. A. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1590 · Cited by 100 · see citing works
Dou, C., Zhang, C., Kang, F., Yang, X., Jiang, H., Bai, Y., Xiang, J., Xu, J., & Dong, S. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.08.002 · Cited by 100 · see citing works
Regulation of cancer metastasis by cell-free miRNAs
Alečković, M., & Kang, Y. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.10.005 · Cited by 100 · see citing works
Mechanisms, Diagnosis and Treatment of Bone Metastases
Ban, J., Fock, V., Aryee, D. N. T., & Kovar, H. (2021) · Cells · doi:10.3390/cells10112944 · Cited by 103 · see citing works
Pantel, K., & Alix‐Panabières, C. (2014) · BoneKEy Reports · doi:10.1038/bonekey.2014.79 · Cited by 96 · see citing works
Liu, X., Cai, F., Liu, L., Zhang, Y., & Yang, A. (2014) · Biological Chemistry · doi:10.1515/hsz-2014-0268 · Cited by 92 · see citing works
miRNA-15a/16: As Tumor Suppressors and More
Huang, E., Liu, R., & Chu, Y. (2015) · Future Oncology · doi:10.2217/fon.15.101 · Cited by 90 · see citing works
Rinnerthaler, G., Hackl, H., Gampenrieder, S. P., Hamacher, F., Hufnagl, C., Hauser‐Kronberger, C., Zehentmayr, F., Fastner, G., Sedlmayer, F., Mlineritsch, B., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020156 · Cited by 90 · see citing works
The role of osteoclasts in breast cancer bone metastasis
le Pape, F., Vargas, G., & Clézardin, P. (2016) · Journal of Bone Oncology · doi:10.1016/j.jbo.2016.02.008 · Cited by 84 · see citing works
MiR-106a-5p inhibits the cell migration and invasion of renal cell carcinoma through targeting PAK5
Pan, Y., Wei, L., Wu, X., Huo, F., Mou, J., & Pei, D. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.561 · Cited by 89 · see citing works
Metastases in Prostate CancerPreprint
Manna, F. L., Karkampouna, S., Zoni, E., Menna, M. D., Hensel, J., Thalmann, G. N., & Julio, M. K. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a033688 · Cited by 92 · see citing works
MicroRNAs as regulators of bone homeostasis and bone metastasis
Ell, B. J., & Kang, Y. (2014) · BoneKEy Reports · doi:10.1038/bonekey.2014.44 · Cited by 86 · see citing works
Taipaleenmäki, H., Farina, N. H., van Wijnen, A. J., Stein, J. L., Hesse, E., Stein, G. S., & Lian, J. B. (2016) · Oncotarget · doi:10.18632/oncotarget.12593 · Cited by 85 · see citing works
Mechanisms of osteolytic and osteoblastic skeletal lesions
Roodman, G. D., & Silbermann, R. W. (2015) · BoneKEy Reports · doi:10.1038/bonekey.2015.122 · Cited by 84 · see citing works
Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer
Liu, J., Li, D., Dang, L., Liang, C., Guo, B., Lu, C. C., He, X., Cheung, H. Y.-S., He, B., Liu, B., et al. (2017) · Scientific Reports · doi:10.1038/srep40487 · Cited by 83 · see citing works
New therapeutic targets for cancer bone metastasis
Krzeszinski, J. Y., & Wan, Y. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.006 · Cited by 82 · see citing works
Plasma miRNAs Effectively Distinguish Patients With Pancreatic Cancer From Controls
Xu, J., Cao, Z., Liu, W., You, L., Zhou, L., Wang, C., Lou, W., Sun, B., Miao, Y., Liu, X., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001345 · Cited by 82 · see citing works
Circulating microRNAs in cancer: Hope or hype?
Singh, R., Ramasubramanian, B., Kanji, S., Chakraborty, A., Haque, S. J., & Chakravarti, A. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.07.002 · Cited by 82 · see citing works
Mechanisms governing metastatic dormancy in breast cancer
Dittmer, J. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.03.006 · Cited by 82 · see citing works
Targeting initial tumour–osteoclast spatiotemporal interaction to prevent bone metastasis
Gu, C., Chen, P., Tian, H., Yang, Y., Huang, Z., Yan, H., Tang, C., Xiang, J., Shangguan, L., Pan, K., et al. (2024) · Nature Nanotechnology · doi:10.1038/s41565-024-01613-5 · Cited by 81 · see citing works
Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patients
Ni, Q., Stevic, I., Pan, C., Müller, V., Oliveira‐Ferrer, L., Pantel, K., & Schwarzenbach, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-31108-y · Cited by 80 · see citing works
Pekarek, L., Torres‐Carranza, D., Fraile‐Μartinez, O., Montero, C. G., Pekarek, T., Sáez, M. A., Rueda-Correa, F., Pimentel-Martinez, C., Guijarro, L. G., Dı́az, R., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087268 · Cited by 76 · see citing works
Bone marrow niches in the regulation of bone metastasis
Chen, F., Han, Y., & Kang, Y. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01329-6 · Cited by 75 · see citing works
Molecular insights into tumour metastasis: tracing the dominant events
Jin, K., Li, T., van Dam, H., Zhou, F.-F., & Zhang, L. (2017) · Journal of Pathology · doi:10.1002/path.4871 · Cited by 59 · see citing works
Mbese, Z., & Aderibigbe, B. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136869 · Cited by 71 · see citing works
Ismail, A., El‐Mahdy, H. A., Abulsoud, A. I., Sallam, A.-A. M., Eldeib, M. G., Elsakka, E. G. E., Zaki, M. B., & Doghish, A. S. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.10.241 · Cited by 67 · see citing works
MicroRNAs: master regulators of drug resistance, stemness, and metastasis
Raza, U., Zhang, J. D., & Şahin, Ö. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1129-2 · Cited by 65 · see citing works
The Role of Bone-Derived Exosomes in Regulating Skeletal Metabolism and Extraosseous Diseases
Lyu, H., Xiao, Y., Guo, Q., Huang, Y., & Luo, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00089 · Cited by 65 · see citing works
Osteocytes and Bone Metastasis
Riquelme, M. A., Cardenas, E. R., & Jiang, J. X. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.567844 · Cited by 65 · see citing works
MicroRNAs in the control of metastatic bone disease
Browne, G., Taipaleenmäki, H., Stein, G. S., Stein, J. L., & Lian, J. B. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.03.014 · Cited by 65 · see citing works
Molecular Regulation of Bone Marrow Metastasis in Prostate and Breast Cancer
Rahim, F., Hajizamani, S., Mortaz, E., Ahmadzadeh, A., Shahjahani, M., Shahrabi, S., & Saki, N. (2014) · Bone Marrow Research · doi:10.1155/2014/405920 · Cited by 64 · see citing works
Deregulated miRNAs in osteoporosis: effects in bone metastasis
Bellavia, D., Salamanna, F., Raimondi, L., Luca, A. D., Carina, V., Costa, V., Alessandro, R., Fini, M., & Giavaresi, G. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03162-w · Cited by 63 · see citing works
Payandeh, Z., Tangruksa, B., Synnergren, J., Heydarkhan‐Hagvall, S., Nordin, J. Z., Andaloussi, S. E., Borén, J., Wiseman, J., Bohlooly‐Y, M., Lindfors, L., et al. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2024.101302 · Cited by 65 · see citing works
The roles of microRNAs in the regulation of tumor metastasis
Zhou, L., Liu, F., Wang, X., & Ouyang, G. (2015) · Cell & Bioscience · doi:10.1186/s13578-015-0028-8 · Cited by 62 · see citing works
MicroRNAs and post-transcriptional regulation of skeletal development
Gámez, B., Rodríguez-Carballo, E., & Ventura, F. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0294 · Cited by 63 · see citing works
Predicting and Overcoming Chemotherapeutic Resistance in Breast Cancer
Chun, K., Park, J. H., & Fan, S. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-6020-5_4 · Cited by 59 · see citing works
Extracellular miR-574-5p Induces Osteoclast Differentiation via TLR 7/8 in Rheumatoid Arthritis
Hegewald, A. B., Breitwieser, K., Ottinger, S. M., Mobarrez, F., Korotkova, M., Réthi, B., Jakobsson, P., Catrina, A. I., Wähämaa, H., & Saul, M. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.585282 · Cited by 62 · see citing works
Liu, X., Liao, W., Peng, H., Luo, X., Luo, Z., Jiang, H., & Xu, L. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-015-1995-1 · Cited by 61 · see citing works
Chen, Y., Sun, J., Dou, C., Li, N., Kang, F., Wang, Y., Cao, Z., Yang, X., & Dong, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091516 · Cited by 61 · see citing works
Role of Runx2 in breast cancer-mediated bone metastasis
Mohanakrishnan, V., Swetha, R., Thejaswini, G., Balasubramanian, A., & Selvamurugan, N. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.03.021 · Cited by 62 · see citing works
Reis, P. P., Drigo, S. A., Carvalho, R. F., Lapa, R. M. L., Felix, T. F., Patel, D., Cheng, D., Pintilie, M., Liu, G., & Tsao, M. (2020) · Cancers · doi:10.3390/cancers12082071 · Cited by 60 · see citing works
Velletri, T., Huang, Y., Wang, Y., Li, Q., Hu, M., Xie, N., Yang, Q., Chen, Q., Chen, Q., Shou, P., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0590-4 · Cited by 58 · see citing works
Lu, F., Zhang, J., Shi, L., Yang, Z., Wu, T., Wang, H., Lin, W., Lu, Y., Lo, J. H. T., Zhu, D., et al. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.07.018 · Cited by 58 · see citing works
Tavallaie, R., Almeida, S. R. M. D., & Gooding, J. J. (2014) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1324 · Cited by 56 · see citing works
Tai, H., Chang, A., Yu, H., Huang, C., Tsai, Y., Lai, Y., Sun, H., Tang, C., & Wang, S. (2014) · Oncotarget · doi:10.18632/oncotarget.2280 · Cited by 55 · see citing works
Chen, G., Luo, Y., Eriksson, D., Meng, X., Cheng, Q., Bäuerle, T., Chen, X., Schett, G. A., & Bözec, A. (2016) · Oncotarget · doi:10.18632/oncotarget.8474 · Cited by 55 · see citing works
Bone turnover markers and novel biomarkers in lung cancer bone metastases
Lang, J., Zhao, Q., He, Y., & Yu, X. (2018) · Biomarkers · doi:10.1080/1354750x.2018.1463566 · Cited by 54 · see citing works
Wang, J., Du, X., Wang, X., Xiao, H., Jing, N., Xue, W., Dong, B., Gao, W., & Fang, Y. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.11.017 · Cited by 54 · see citing works
A polymorphism in the tumor suppressor p53 affects aging and longevity in mouse models
Zhao, Y., Wu, L., Yue, X., Zhang, C., Wang, J., Li, J., Sun, X., Zhu, Y., Feng, Z., & Hu, W. (2018) · eLife · doi:10.7554/elife.34701 · Cited by 53 · see citing works
miR-590-3p is a novel microRNA which suppresses osteosarcoma progression by targeting SOX9
Wang, W., Qi, Q., Zhao, P., Li, C.-Y., Yin, X.-Y., & Yan, R. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.124 · Cited by 53 · see citing works
Reference miRNAs for colorectal cancer: analysis and verification of current data
Danese, E., Minicozzi, A. M., Benati, M., Paviati, E., Lima-Oliveira, G., Gusella, M., Pasini, F., Salvagno, G. L., Montagnana, M., & Lippi, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-08784-3 · Cited by 52 · see citing works
Runx2 Suppression by miR-342 and miR-363 Inhibits Multiple Myeloma Progression
Gowda, P. S., Wildman, B. J., Trotter, T. N., Xu, X., Hao, X., Hassan, M. Q., & Yang, Y. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0606 · Cited by 53 · see citing works
- Authors
- Ell, B., Mercatali, L., Ibrahim, T., Campbell, N., Schwarzenbach, H., Pantel, K., Amadori, D., & Kang, Y.
- Affiliations
- Princeton University (US)
- Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IT)
- Rutgers Cancer Institute (US)
- Universität Hamburg (DE)
- Corresponding author
- Kang, Yibin
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2013-10
- Volume
- 24
- Issue
- 4
- Pages
- 542-556
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC3832956
- OpenAlex
- W2054148405
- Cited by
- 266
- References
- 41
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 7 · 2023: 8 · 2022: 15 · 2021: 27 · 2020: 25 · 2019: 23 · 2018: 31 · 2017: 22 · 2016: 30 · 2015: 31 · 2014: 33 · 2013: 2
- FWCI
- 14.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA141062, R01CA134519, P30CA072720)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Keywords
- osteoclastogenesis, osteolytic bone metastasis, microRNA, tumor-conditioned medium, NF-κB signaling, miR-16, miR-378, serum biomarkers, microRNA delivery, therapeutic target
- MeSH terms
- Animals, Bone Neoplasms, Bone Resorption, Humans, Neoplasm Metastasis, Osteoclasts, Osteolysis, Biomarkers, Tumor, NF-kappa B, Culture Media, Conditioned, Intercellular Adhesion Molecule-1, CD18 Antigens, MicroRNAs, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review